Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Tsirigotaki, M. Galanakis, E.

Impact of vaccines on Staphylococcus aureus colonization: A systematic review and meta-analysis

  • Newborn
  • Children
  • Adults
  • Parents/caregivers
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Patikorn, Chanthawat Kategeaw, Warittakorn Perdrizet, Johnna Li, Xiuyan Chaiyakunapruk, Nathorn

Implementation challenges and real-world impacts of switching pediatric vaccines: A global systematic literature review

  • Newborn
  • Children
  • Parents/caregivers
  • Acceptance
  • Logistics
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Adu, P. Poopola, T. Medvedev, O. N. Collings, S. Mbinta, J. Aspin, C. Simpson, C. R.

Implications for COVID-19 vaccine uptake: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Soltanzadi, A. Mirmosayyeb, O. Momeni Moghaddam, A. Ghoshouni, H. Ghajarzadeh, M.

Incidence of Bell's palsy after Coronavirus disease (COVID-19) vaccination: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Guo, B. Q. Li, H. B. Yang, L. Q.

Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12–17 years

  • Adolescents
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Moderate
2023 ∙ Atnafu Gebeyehu, Natnael Abebe Gelaw, Kelemu Asmare Adella, Getachew Dagnaw Tegegne, Kirubel Adie Admass, Biruk Mesele Gesese, Molalegn

Incomplete immunization and its determinants among children in Africa: Systematic review and meta-analysis

  • Africa
  • Newborn
  • Children
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Santoli, G. Nurchis, M. C. Calabrò, G. E. Damiani, G.

Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence

  • All age groups
  • COVID-19
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Giddings, Rebecca Indravudh, Pitchaya Medley, Graham F. Bozzani, Fiammetta Gafos, Mitzy Malhotra, Shelly Terris-Prestholt, Fern Torres-Rueda, Sergio Quaife, Matthew

Infectious Disease Modelling of HIV Prevention Interventions: A Systematic Review and Narrative Synthesis of Compartmental Models

  • All age groups
  • HIV / AIDS
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Modin, D. Lassen, M. C. H. Claggett, B. Johansen, N. D. Keshtkar-Jahromi, M. Skaarup, K. G. Nealon, J. Udell, J. A. Vardeny, O. Solomon, S. D. Gislason, G. Biering-Sørensen, T.

Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: A meta-analysis

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Barbetta, Leticia Mara Dos Santos Correia, Eduardo Thadeu de Oliveira Gismondi, Ronaldo Altenburg Odebrecht Curi Mesquita, Evandro Tinoco

Influenza Vaccination as Prevention Therapy for Stable Coronary Artery Disease and Acute Coronary Syndrome: A Meta-Analysis of Randomized Trials

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...